Active — Not RecruitingNot Applicable

Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE

United States2,870 participantsStarted 2022-04-21

Plain-language summary

The PREVUE-VALVE study will establish reliable, population-based estimates of Valvular Heart Disease (VHD) prevalence among older Americans and allow for the development and validation of several innovative tools to aid in the detection and diagnosis of Valvular Heart Disease (VHD).

Who can participate

Age range65 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 65-85 * Ability to provide informed consent * Stably domiciled in a residence that can be accessed by study personnel Exclusion Criteria: * History of complex congenital heart disease

What they're measuring

Prevalence of Valvular Heart Disease

Timeframe: Baseline

Trial details

NCT IDNCT05357404

SponsorCardiovascular Research Foundation, New York

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-31

View on ClinicalTrials.gov More Valvular Heart Disease trials